The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
Intrinsic basal and luminal subtypes of muscle-invasive bladder cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,166
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., et al. (1999) · Science · doi:10.1126/science.286.5439.531 · Cited by 11,516
Sørlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 10,938
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., et al. (2000) · Nature · doi:10.1038/35000501 · Cited by 9,925
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
Repeated observation of breast tumor subtypes in independent gene expression data sets
Sørlie, T., Tibshirani, R., Parker, J., Hastie, T., Marron, J. S., Nobel, A., Deng, S., Johnsen, H., Pesich, R., Geisler, S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932692100 · Cited by 5,429
Elkablawy, M. A., Albasri, A. M., Mohammed, R. A., Hussainy, A. S., Nouh, M. M., & Alhujaily, A. S. (2016) · Saudi Medical Journal · doi:10.15537/smj.2016.2.12285 · Cited by 4,382
Gregory, P. A., Bert, A. G., Paterson, E. L., Barry, S. C., Tsykin, A., Farshid, G., Vadas, M. A., Khew-Goodall, Y., & Goodall, G. J. (2008) · Nature Cell Biology · doi:10.1038/ncb1722 · Cited by 3,863
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., Savagner, P., Gitelman, I., Richardson, A., & Weinberg, R. A. (2004) · Cell · doi:10.1016/j.cell.2004.06.006 · Cited by 3,855
Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study
Carey, L. A., Perou, C. M., Livasy, C. A., Dressler, L. G., Cowan, D., Conway, K., Karaca, G., Troester, M. A., Tse, C. K., Edmiston, S., et al. (2006) · JAMA · doi:10.1001/jama.295.21.2492 · Cited by 3,819
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
Zhang, L., Conejo-Garcia, J. R., Katsaros, D., Gimotty, P. A., Massobrio, M., Regnani, G., Makrigiannakis, A., Gray, H., Schlienger, K., Liebman, M. N., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020177 · Cited by 3,397
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
Polyak, K., & Weinberg, R. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2620 · Cited by 3,302
Comprehensive molecular characterization of urothelial bladder carcinoma
Perou, C. M. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/za09-dk57 · Cited by 2,990
15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90193-0 · Cited by 2,858
Grossman, H. B., Natale, R. B., Tangen, C. M., Speights, V. O., Vogelzang, N. J., Trump, D. L., White, R. W. D., Sarosdy, M. F., Wood, D. P., Raghavan, D., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022148 · Cited by 2,668
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
Yu, M., Bardia, A., Wittner, B. S., Stott, S. L., Smas, M. E., Ting, D. T., Isakoff, S. J., Ciciliano, J. C., Wells, M. N., Shah, A. M., et al. (2013) · Science · doi:10.1126/science.1228522 · Cited by 2,476
p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development
Yang, A., Schweitzer, R., Sun, D., Kaghad, M., Walker, N., Bronson, R. T., Tabin, C., Sharpe, A., Caput, D., Crum, C., et al. (1999) · Nature · doi:10.1038/19539 · Cited by 2,225
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
Prat, A., Parker, J. S., Karginova, O., Fan, C., Livasy, C., Herschkowitz, J. I., He, X., & Perou, C. M. (2010) · Breast Cancer Research · doi:10.1186/bcr2635 · Cited by 2,167
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
Pagès, F., Berger, A., Camus, M., Sanchez-Cabo, F., Costes, A., Molidor, R., Mlecnik, B., Kirilovsky, A., Nilsson, M., Damotte, D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051424 · Cited by 2,135
Labelle, M., Begum, S., & Hynes, R. O. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.09.009 · Cited by 1,833
Denkert, C., Loibl, S., Noske, A., Roller, M., Müller, B. M., Komor, M., Budczies, J., Darb-Esfahani, S., Kronenwett, R., Hanusch, C., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.7370 · Cited by 1,762
Choi, W., Porten, S., Kim, S., Willis, D., Plimack, E. R., Hoffman-Censits, J., Roth, B., Cheng, T., Tran, M., Lee, I.-L., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.01.009 · Cited by 1,716
Self-citationTsai, J. H., Donaher, J. L., Murphy, D. A., Chau, S., & Yang, J. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.09.022 · Cited by 1,071
Taube, J. H., Herschkowitz, J. I., Komurov, K., Zhou, A. Y., Gupta, S., Yang, J., Hartwell, K., Onder, T. T., Gupta, P. B., Evans, K. W., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004900107 · Cited by 1,041
Circulating tumor cells (CTC) detection: Clinical impact and future directions
Paterlini-Brechot, P., & Benali, N. L. (2007) · Cancer Letters · doi:10.1016/j.canlet.2006.12.014 · Cited by 947
A Molecular Taxonomy for Urothelial Carcinoma
Sjödahl, G., Lauss, M., Lövgren, K., Chebil, G., Gudjonsson, S., Veerla, S., Patschan, O., Aine, M., Fernö, M., Ringnér, M., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0077-t · Cited by 944
Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology
Damrauer, J. S., Hoadley, K. A., Chism, D. D., Fan, C., Tiganelli, C. J., Wobker, S. E., Yeh, J. J., Milowsky, M. I., Iyer, G., Parker, J. S., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318376111 · Cited by 877
Chaffer, C. L., Marjanovic, N. D., Lee, T., Bell, G., Kleer, C. G., Reinhardt, F., D’Alessio, A. C., Young, R. A., & Weinberg, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.06.005 · Cited by 876
Collective Invasion in Breast Cancer Requires a Conserved Basal Epithelial Program
Cheung, K. J., Gabrielson, E., Werb, Z., & Ewald, A. J. (2013) · Cell · doi:10.1016/j.cell.2013.11.029 · Cited by 833
Identification of Targetable FGFR Gene Fusions in Diverse Cancers
Wu, Y.-M., Su, F., Kalyana-Sundaram, S., Khazanov, N., Ateeq, B., Cao, X., Lonigro, R. J., Vats, P., Wang, R., Lin, S.-F., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0050 · Cited by 744
Genome Sequencing Identifies a Basis for Everolimus Sensitivity
Iyer, G., Hanrahan, A. J., Milowsky, M. I., Al-Ahmadie, H., Scott, S. N., Janakiraman, M., Pirun, M., Sander, C., Socci, N. D., Ostrovnaya, I., et al. (2012) · Science · doi:10.1126/science.1226344 · Cited by 690
Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression
Chung, C. H., Parker, J. S., Karaca, G., Wu, J., Funkhouser, W. K., Moore, D., Butterfoss, D., Xiang, D., Zanation, A., Yin, X., et al. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00112-6 · Cited by 678
Latent Bone Metastasis in Breast Cancer Tied to Src-Dependent Survival Signals
Zhang, X. H.-F., Wang, Q., Gerald, W., Hudis, C. A., Norton, L., Smid, M., Foekens, J. A., & Massagué, J. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.05.017 · Cited by 663
Chan, K. S., Espinosa, I., Chao, M., Wong, D., Ailles, L., Diehn, M., Gill, H., Presti, J., Chang, H. Y., van de Rijn, M., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906549106 · Cited by 660
Gianni, L., Zambetti, M., Clark, K., Baker, J., Cronin, M., Wu, J., Mariani, G., Rodriguez, J., Carcangiu, M., Watson, D., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.0818 · Cited by 626
Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis
Visvader, J. E. (2009) · Genes & Development · doi:10.1101/gad.1849509 · Cited by 571
Ellis, M. J., Suman, V. J., Hoog, J., Lin, L., Snider, J., Prat, A., Parker, J. S., Luo, J., DeSchryver, K., Allred, D. C., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.6950 · Cited by 551
Sanchez-Carbayo, M., Socci, N. D., Lozano, J., Saint, F., & Cordon-Cardo, C. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.2375 · Cited by 550
Liakou, C. I., Kamat, A., Tang, D. N., Chen, H., Sun, J., Troncoso, P., Logothetis, C., & Sharma, P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806075105 · Cited by 549
Grandis, J. R., Drenning, S. D., Chakraborty, A., Zhou, M. Y., Zeng, Q., Pitt, A. S., & Tweardy, D. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3785 · Cited by 507
Identifying distinct classes of bladder carcinoma using microarrays
Dyrskjøt, L., Thykjaer, T., Kruhøffer, M., Jensen, J. L., Marcussen, N., Hamilton-Dutoit, S., Wolf, H., & Ørntoft, T. F. (2003) · Nature Genetics · doi:10.1038/ng1061 · Cited by 501
Carthon, B. C., Wolchok, J. D., Yuan, J., Kamat, A., Ng Tang, D. S., Sun, J., Ku, G., Troncoso, P., Logothetis, C. J., Allison, J. P., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0569 · Cited by 460
Esserman, L. J., Berry, D. A., DeMichele, A., Carey, L., Davis, S. E., Buxton, M., Hudis, C., Gray, J. W., Perou, C., Yau, C., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.2779 · Cited by 438
Selection of Bone Metastasis Seeds by Mesenchymal Signals in the Primary Tumor Stroma
Zhang, X. H.-F., Jin, X., Malladi, S., Zou, Y., Wen, Y. H., Brogi, E., Smid, M., Foekens, J. A., & Massagué, J. (2013) · Cell · doi:10.1016/j.cell.2013.07.036 · Cited by 425
Adam, L., Zhong, M., Choi, W., Qi, W., Nicoloso, M., Arora, A., Calin, G., Wang, H., Siefker-Radtke, A., McConkey, D., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2245 · Cited by 412
Self-citationp63 regulates an adhesion programme and cell survival in epithelial cells
Carroll, D. K., Carroll, J. S., Leong, C.-O., Cheng, F., Brown, M., Mills, A. A., Brugge, J. S., & Ellisen, L. W. (2006) · Nature Cell Biology · doi:10.1038/ncb1420 · Cited by 403
Oncogenic FGFR3 gene fusions in bladder cancer
Williams, S. V., Hurst, C. D., & Knowles, M. A. (2013) · Human Molecular Genetics · doi:10.1093/hmg/dds486 · Cited by 390
Genomic aberrations in the FGFR pathway: opportunities for targeted therapies in solid tumors
Dienstmann, R., Rodon, J., Prat, A., Perez-Garcia, J., Adamo, B., Felip, E., Cortes, J., Iafrate, A. J., Nuciforo, P., & Tabernero, J. (2014) · Annals of Oncology · doi:10.1093/annonc/mdt419 · Cited by 365
Shibue, T., & Weinberg, R. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904227106 · Cited by 364
The I-SPY 1 TRIAL Investigators, Esserman, L. J., Berry, D. A., Cheang, M. C. U., Yau, C., Perou, C. M., Carey, L., DeMichele, A., Gray, J. W., Conway-Dorsey, K., et al. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1895-2 · Cited by 362
Pathological Complete Response and Accelerated Drug Approval in Early Breast Cancer
Prowell, T. M., & Pazdur, R. (2012) · New England Journal of Medicine · doi:10.1056/nejmp1205737 · Cited by 342
Bladder Cancer Outcome and Subtype Classification by Gene Expression
Blaveri, E., Simko, J. P., Korkola, J. E., Brewer, J. L., Baehner, F., Mehta, K., DeVries, S., Koppie, T., Pejavar, S., Carroll, P., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2409 · Cited by 337
Jackson, J. G., Pant, V., Li, Q., Chang, L. L., Quintás-Cardama, A., Garza, D., Tavana, O., Yang, P., Manshouri, T., Li, Y., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.04.027 · Cited by 329
Lee, J. K., Havaleshko, D. M., Cho, H., Weinstein, J. N., Kaldjian, E. P., Karpovich, J., Grimshaw, A., & Theodorescu, D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610292104 · Cited by 316
Lindgren, D., Frigyesi, A., Gudjonsson, S., Sjödahl, G., Hallden, C., Chebil, G., Veerla, S., Ryden, T., Månsson, W., Liedberg, F., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4213 · Cited by 310
Prevalence and Co-Occurrence of Actionable Genomic Alterations in High-Grade Bladder Cancer
Iyer, G., Al-Ahmadie, H., Schultz, N., Hanrahan, A. J., Ostrovnaya, I., Balar, A. V., Kim, P. H., Lin, O., Weinhold, N., Sander, C., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.5740 · Cited by 309
Practical implications of gene-expression-based assays for breast oncologists
Prat, A., Ellis, M. J., & Perou, C. M. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.178 · Cited by 295
Dinney, C. P. N., McConkey, D. J., Millikan, R. E., Wu, X., Bar-Eli, M., Adam, L., Kamat, A. M., Siefker-Radtke, A. O., Tuziak, T., Sabichi, A. L., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.08.002 · Cited by 290
Self-citationWelsh, S. J., Williams, R. R., Kirkpatrick, L., Paine-Murrieta, G. D., & Powis, G. (2004) · PubMed · Cited by 280
Wilkerson, M. D., Yin, X., Hoadley, K. A., Liu, Y., Hayward, M. C., Cabanski, C. R., Muldrew, K., Miller, C. R., Randell, S. H., Socinski, M. A., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0199 · Cited by 278
Rimawi, M. F., Mayer, I. A., Forero, A., Nanda, R., Goetz, M. P., Rodriguez, A. A., Pavlick, A. C., Wang, T., Hilsenbeck, S. G., Gutierrez, C., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.44.8027 · Cited by 274
Welsh, S., Williams, R., Kirkpatrick, L., Paine-Murrieta, G., & Powis, G. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.233.3.3 · Cited by 240
Inoue, K., Slaton, J. W., Perrotte, P., Davis, D. W., Bruns, C. J., Hicklin, D. J., McConkey, D. J., Sweeney, P., Radinsky, R., & Dinney, C. P. (2000) · PubMed · Cited by 238
Self-citationThe Outgrowth of Micrometastases Is Enabled by the Formation of Filopodium-like Protrusions
Shibue, T., Brooks, M. W., Inan, M. F., Reinhardt, F., & Weinberg, R. A. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0239 · Cited by 212
Small Molecule Inhibitors of Signal Transducer and Activator of Transcription 3 (Stat3) Protein
Debnath, B., Xu, S., & Neamati, N. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300207s · Cited by 202
Shibue, T., Brooks, M. W., & Weinberg, R. A. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.08.012 · Cited by 194
Shen, S. S., Smith, C. L., Hsieh, J., Yu, J., Kim, I. Y., Jian, W., Sonpavde, G., Ayala, G. E., Younes, M., & Lerner, S. P. (2006) · Cancer · doi:10.1002/cncr.21945 · Cited by 192
Normal and neoplastic urothelial stem cells: getting to the root of the problem
Ho, P. L., Kurtova, A., & Chan, K. S. (2012) · Nature Reviews Urology · doi:10.1038/nrurol.2012.142 · Cited by 184
Tran, M., Choi, W., Wszolek, M. F., Navai, N., Lee, I.-L. C., Nitti, G., Wen, S., Flores, E. R., Siefker-Radtke, A. O., Czerniak, B. A., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.408104 · Cited by 182
Self-citationToward a Molecular Pathologic Classification of Urothelial Carcinoma
Sjödahl, G., Lövgren, K., Lauss, M., Patschan, O., Gudjonsson, S., Chebil, G., Aine, M., Eriksson, P., Månsson, W., Lindgren, D., et al. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.05.013 · Cited by 180
Lamont, F. R., Tomlinson, D. C., Cooper, P. A., Shnyder, S. D., Chester, J. D., & Knowles, M. A. (2011) · British Journal of Cancer · doi:10.1038/sj.bjc.6606016 · Cited by 180
Role of PPAR γ and EGFR signalling in the urothelial terminal differentiation programme
Varley, C. L., Stahlschmidt, J., Lee, W.-C., Holder, J., Diggle, C., Selby, P. J., Trejdosiewicz, L. K., & Southgate, J. (2004) · Journal of Cell Science · doi:10.1242/jcs.01042 · Cited by 175
Sternberg, C. N., Bellmunt, J., Sonpavde, G., Siefker-Radtke, A. O., Stadler, W. M., Bajorin, D. F., Dreicer, R., George, D. J., Milowsky, M. I., Theodorescu, D., et al. (2013) · European Urology · doi:10.1016/j.eururo.2012.08.010 · Cited by 170
Self-citationPhosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancer
Knowles, M. A., Platt, F. M., Ross, R. L., & Hurst, C. D. (2009) · Cancer and Metastasis Reviews · doi:10.1007/s10555-009-9198-3 · Cited by 168
Ross, J. S., Wang, K., Gay, L. M., Al-Rohil, R. N., Nazeer, T., Sheehan, C. E., Jennings, T. A., Otto, G. A., Donahue, A. L., He, J., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1992 · Cited by 158
Karni-Schmidt, O., Castillo-Martín, M., HuaiShen, T., Gladoun, N., Domenech, J. M. D., Sänchez‐Carbayo, M., Li, Y., Lowe, S. W., Prives, C. L., & Cordon‐Cardo, C. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2010.11.061 · Cited by 145
Label-retaining cells of the bladder: candidate urothelial stem cells
Kurzrock, E. A., Lieu, D. K., deGraffenried, L. A., Chan, C. W. Y., & Isseroff, R. R. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00533.2007 · Cited by 141
Differentiation of a Highly Tumorigenic Basal Cell Compartment in Urothelial Carcinoma
He, X., Marchionni, L., Hansel, D. E., Yu, W., Sood, A., Yang, J., Parmigiani, G., Matsui, W. H., & Berman, D. M. (2009) · Stem Cells · doi:10.1002/stem.92 · Cited by 138
Stat3 Activation in Urothelial Stem Cells Leads to Direct Progression to Invasive Bladder Cancer
Ho, P. L., Lay, E. J., Jian, W., Parra, D., & Chan, K. S. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3195 · Cited by 134
Herrera-Abreu, M. T., Pearson, A., Campbell, J., Shnyder, S. D., Knowles, M. A., Ashworth, A., & Turner, N. C. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0569 · Cited by 132
Sonpavde, G., Sternberg, C. N., Rosenberg, J. E., Hahn, N. M., Galsky, M. D., & Vogelzang, N. J. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70086-3 · Cited by 131
Wong, Y., Litwin, S., Vaughn, D. J., Cohen, S., Plimack, E. R., Lee, J. D., Song, W., Dabrow, M. B., Brody, M. B., Tuttle, H., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.41.9572 · Cited by 129
Xu, S., Grande, F., Garofalo, A., & Neamati, N. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-1082 · Cited by 125
Glycobiology and Cancer: Meeting Summary and Future Directions
Hart, G. W., Lowe, J. B., & Sathyamoorthy, N. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.2.775 · Cited by 122
Brown, J. R., DiGiovanna, M. P., Killelea, B. K., Lannin, D. R., & Rimm, D. L. (2013) · Laboratory Investigation · doi:10.1038/labinvest.2013.128 · Cited by 112
Black, P. C., Brown, G. A., Inamoto, T., Shrader, M., Arora, A., Siefker-Radtke, A. O., Adam, L., Theodorescu, D., Wu, X., Munsell, M. F., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1593 · Cited by 109
Self-citationNew Strategies in Muscle-Invasive Bladder Cancer: On the Road to Personalized Medicine
Shah, J. B., McConkey, D. J., & Dinney, C. P. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2770 · Cited by 108
Self-citationVarley, C. L., Stahlschmidt, J., Smith, B. A., Stower, M. J., & Southgate, J. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63737-6 · Cited by 107
p63 Expression Defines a Lethal Subset of Muscle-Invasive Bladder Cancers
Choi, W., Shah, J. B., Tran, M., Svatek, R. S., Marquis, L., Lee, I.-L., Yu, D., Adam, L., Wen, S., Shen, Y., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030206 · Cited by 104
Self-citationDominick, M. A., White, M. R., Sanderson, T. P., Vleet, T. V., Cohen, S. M., Arnold, L. L., Cano, M., Tannehill‐Gregg, S. H., Moehlenkamp, J. D., Waites, C. R., et al. (2006) · Toxicologic Pathology · doi:10.1080/01926230601072327 · Cited by 96
Kassouf, W., Chintharlapalli, S. R., Abdelrahim, M., Nelkin, G. M., Safe, S. H., & Kamat, A. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2755 · Cited by 95
Hsu, I., Chuang, K., Slavin, S. A., Da, J., Lim, W.-X., Pang, S.-T., O’Brien, J. H., & Yeh, S. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt348 · Cited by 92
Slaton, J. W., Millikan, R. E., Inoue, K., Karashima, T., Czerniak, B. A., Shen, Y., Yang, Y., Benedict, W. F., & Dinney, C. P. (2004) · The Journal of Urology · doi:10.1097/01.ju.0000108845.91485.20 · Cited by 80
Self-citationCheng, T., Roth, B., Choi, W., Black, P. C., Dinney, C. P., & McConkey, D. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057284 · Cited by 77
Self-citationNam, S., Wen, W. X., Schroeder, A., Herrmann, A., Yu, H., Cheng, X., Merz, K., Eisenbrand, G., Li, H., Yuan, Y., et al. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.10.013 · Cited by 75
Role of oestrogen receptors in bladder cancer development
Hsu, I., Vitkus, S., Da, J., & Yeh, S. (2013) · Nature Reviews Urology · doi:10.1038/nrurol.2013.53 · Cited by 75
Novel Therapeutic Targets In Bladder Cancer: Mutation and Expression of Fgf Receptors
Knowles, M. A. (2008) · Future Oncology · doi:10.2217/14796694.4.1.71 · Cited by 70
Molecular correlates of gefitinib responsiveness in human bladder cancer cells
Shrader, M., Pino, M. S., Brown, G. A., Black, P. C., Adam, L., Bar-Eli, M., Dinney, C. P., & McConkey, D. J. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0513 · Cited by 68
Self-citationEgerod, F. L., Nielsen, H. S., Iversen, L., Thorup, I., Storgaard, T., & Oleksiewicz, M. B. (2005) · Biomarkers · doi:10.1080/13547500500218682 · Cited by 52
Liu, L., Kritsanida, M., Magiatis, P., Gaboriaud‐Kolar, N., Wang, Y., Wu, J., Buettner, R., Yang, F., Nam, S., Skaltsounis, A., et al. (2012) · Cancer Biology & Therapy · doi:10.4161/cbt.21781 · Cited by 35
Schedule Dependent Efficacy of Gefitinib and Docetaxel for Bladder Cancer
Kassouf, W., Luongo, T., Brown, G. A., et al. (2006) · The Journal of Urology · doi:10.1016/j.juro.2006.03.072 · Cited by 34
Faillie, J., Petit, P., Montastruc, J., & Hillaire‐Buys, D. (2013) · Drug Safety · doi:10.1007/s40264-013-0086-y · Cited by 27
Inhibiting the Hypoxia Response for Cancer Therapy: The New Kid on the Block
Koh, M. Y., Spivak-Kroizman, T. R., & Powis, G. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1650 · Cited by 25
Egerod, F. L., Brünner, N., Svendsen, J. E., & Oleksiewicz, M. B. (2009) · Journal of Applied Toxicology · doi:10.1002/jat.1481 · Cited by 16
Cited by
Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer
Robertson, A. G., Kim, J., Al-Ahmadie, H., Bellmunt, J., Guo, G., Cherniack, A. D., Hinoue, T., Laird, P. W., Hoadley, K. A., Akbani, R., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.007 · Cited by 2,443
Self-citationHumphrey, P. A., Moch, H., Cubilla, A. L., Ulbright, T. M., & Reuter, V. E. (2016) · European Urology · doi:10.1016/j.eururo.2016.02.028 · Cited by 1,916
Sharma, P., Retz, M., Siefker-Radtke, A., Baron, A., Necchi, A., Bedke, J., Plimack, E. R., Vaena, D., Grimm, M.-O., Bracarda, S., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30065-7 · Cited by 1,736
Self-citationMolecular biology of bladder cancer: new insights into pathogenesis and clinical diversity
Knowles, M. A., & Hurst, C. D. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3817 · Cited by 1,247
5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs
Chen, X., Li, A., Sun, B.-F., Yang, Y., Han, Y.-N., Yuan, X., Chen, R.-X., Wei, W.-S., Liu, Y., Gao, C.-C., et al. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0361-y · Cited by 801
Metadata
- Authors
- Choi, W., Czerniak, B., Ochoa, A., Su, X., Siefker-Radtke, A., Dinney, C., & McConkey, D. J.
- Venue
- Nature Reviews Urology
- Published
- 2014-06-24
- Volume
- 11
- Issue
- 7
- Pages
- 400-410
- ISSN
- 1759-4812 (ISSN-L)
- 1759-4820
- OpenAlex
- W1980808101
- Cited by
- 302
- References
- 109
- FWCI
- 5.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.